Angiogenic factor with G-patch and FHA domains 1 pseudogene 4 (AGGF1P4)

Angiogenic factor with G-patch and FHA domains 1 pseudogene 4 (AGGF1P4) is a processed pseudogene located in the human genome[1][2][4][7][9]. This locus does not encode a functional protein product and is generally considered non-protein-coding. AGGF1P4 is related by sequence to the parental gene angiogenic factor with G-patch and FHA domains 1 (AGGF1), which is a gene involved in endothelial cell proliferation and angiogenesis, but AGGF1P4 itself is not known to be transcribed into a protein or act as a classical biological target[5][7][9]. While AGGF1P4 itself is not recognized as a disease gene or a therapeutic target, pseudogenes can have regulatory functions at the RNA level, such as acting as microRNA decoys, antisense transcripts, or generating small interfering RNAs that might modulate gene expression[3][8]. Such functions have been described for other pseudogenes (not specifically for AGGF1P4), suggesting broad regulatory roles in gene networks, but no specific functional data or drug associations for AGGF1P4 are documented. Summary of structure and conventions: - AGGF1P4 is not a protein, receptor, enzyme, transporter, or other classical drug target. - It is not used as a biomarker or known to be involved in drug response, toxicity, or therapy selection. - No safety, efficacy, or clinical concerns are noted, as it is not targeted pharmacologically. - The entry is likely "incorrect" or "missing information" if used in a list of therapeutic targets, as it is a pseudogene without known direct therapeutic relevance.

Other names

AGGF1P4